Although U.S. Patent and Trademark Office (USPTO) Director John Squires just officially announced last week that former counsel to Judge Pauline Newman, Greg Dolin, will be the new Deputy General Counsel and Solicitor, following the appointment of John Duffy as General Counsel last month, nearly 14 months after Squires became Director on September 22, 2025, the agency continues to operate with significant leadership vacancies, temporary appointments, and weakened oversight.
This Week in Other Barks & Bites: the Federal Circuit rules that the inoperability of a prior art reference in combination with another does not extinguish the motivation to combine those references; the U.S. Trade Representative extends its Special 301 investigation into Vietnam’s IP practices through next February; and more.
On Tuesday, a memorandum issued to administrative patent judges (APJs) of the Patent Trial and Appeal Board (PTAB) by U.S. Patent and Trademark Office Director John Squires and USPTO’s General Counsel John Duffy announced that effective November 16, 2026, Director Squires would be relinquishing direct oversight on merits-based PTAB institution decisions to PTAB panels. The decision to return institution decisions back to the PTAB panels themselves has been in the works for several months, as was first reported by IPWatchdog in September. Giving PTAB panels the authority to decide which cases to institute comes just more than one-year after Squires centralized the decision-making power in the Director’s Office.
Several recent federal appellate and district court decisions underscore that companies must promptly investigate and act on suspected trade secret theft. Delay can cost a trade secret owner an otherwise meritorious claim. The risk is compounded by uncertainty over when the Defend Trade Secrets Act’s (DTSA) three-year limitations period begins.
On October 15, 2026, a TESLA ROADSTER hung upside down, flipped into the air, and briefly hovered. Powered fans supplied suction for inverted travel. Cold-gas thrusters drawing on SPACEX technology controlled the airborne maneuver. The engineering question was how to make a car fly. The commercial question is what else that car could sell.
Congress may soon abandon a principle that has guided the U.S. legal system for generations: the ability to obtain and enforce patent rights should not depend on the type of technology being invented. Straying from this core tenet risks weakening a key competitive advantage of the American innovation economy.
We live and practice in a time when it may seem to some patent litigators that it would border on malpractice to not move for attorney fees after any case is won. You don’t ask, you don’t get, right? What do we have to lose? The recent U.S. Court of Appeals for the Federal Circuit decision in Chromadex v. Elysium Health serves as a helpful reminder of the seemingly obvious notion that not all patent cases we win (or, for that matter, lose) are “exceptional.” And it suggests that overreaching in seeking fees may itself come with some costs.
This week on IPWatchdog Unleashed, we discuss how a credible trial preparation supports settlement leverage. From the in-house vantage point, a litigation team’s ability to articulate a persuasive case matters even when the preferred outcome is an early resolution. For patent owners, accused infringers, and the counsel advising them, this conversation highlights why audience awareness, technical clarity, and case development belong within the same strategy. The episode offers a substantive look at how experienced practitioners make those judgments—and how the choices made throughout a case shape both courtroom advocacy and the options available outside it.
Epic Tech’s U.S. Patent No. 8,545,317, directed to a networked electronic sweepstakes system, issued in October 2013. Alice Corp. v. CLS Bank came eight months later. Over the next several years, the U.S. Patent and Trademark Office (USPTO) rejected claims in three related Epic Tech applications under Section 101, having already found claims in two of them patentably indistinct from the ‘317 claims, and Epic Tech abandoned all three. A district court in Texas then held claims of the sibling ‘315 patent ineligible. In June 2020, six years after Alice, Epic Tech sued Pen-Tech Associates on the ‘317 patent.
Copyright and trademark rights act in tension with the First Amendment. Indeed, “unlike other property rights, [these] are a form of content-based, government-imposed speech restriction.” (Mark Lemley and Eugene Volokh, Freedom of Speech and Injunctions in Intellectual Property Cases, 48 Duke L.J. 147, 206 (1998)). As such, courts have determined that criticism, generally, puts the critic beyond the reach of a copyright or trademark claim.
Today, the U.S. Supreme Court denied the petition for writ of certiorari filed in Genuine Enabling Technology LLC v. Sony Group Corp., which challenged lower court rulings dismissing Genuine Enabling Technology’s (GET) patent infringement claims against Sony Playstation controllers under the doctrine of equivalents. In denying cert, the Court avoided clarifying whether a patentee’s statutory presumption under 35 U.S.C. § 112(f) to equivalents of a means-plus-function claim can be extinguished as a matter of law for failing to account for each component of the claimed structure.
Every U.S. Patent and Trademark Office (USPTO) Director leaves office. Very few leave a legacy that could fundamentally change the future of American innovation. Director John A. Squires has an extraordinary opportunity to do just that. For more than a decade, independent inventors, startups, small businesses, universities, and those investing in American innovation have asked Congress to address the unintended consequences of the America Invents Act (AIA) and the Patent Trial and Appeal Board (PTAB). Congress held hearings. Members acknowledged the problems. Legislation was introduced. Organizations rallied behind reform. Year after year, inventors traveled to Washington, told their stories, and pleaded for meaningful change. And year after year, the problems remained. Then came Director Squires.
Technology collaboration between the United States and Korea has grown quickly, from semiconductors and artificial intelligence to biotechnology and advanced manufacturing. More joint research agreements are being signed, but the importance of their IP provisions is often overlooked. This can cause problems later, because the two countries have different legal rules that even experienced counsel can miss.
Earlier this year, with an effective date of April 9, 2026, the United States Patent and Trademark Office (USPTO) introduced the Patent Cooperation Treaty (PCT) Informed Examination Request (PIER) Pilot Program. Curiously, while most USPTO pilot programs allow the applicant to opt in or opt out, the PIER Pilot Program precludes input from the applicant on the matter and rather imposes itself on the applicant. The USPTO decides which applications will take part in the PIER Pilot Program, and the decision is not challengeable.
This week in Other Barks & Bites: The U.S. Patent and Trademark Office (USPTO) has sworn in former counsel to Judge Pauline Newman as Solicitor; Reuters reports that this week’s massive tech selloff could delay the anticipated initial public offering of Anthropic stock; the Western District of Washington releases an unredacted version of the Federal Trade Commission’s complaint over Amazon’s covert price shifting for ad auctions; a Government Accountability Office Report shows that backlog reduction efforts at the USPTO are contributing to patent examiner attrition, in turn making agency goals unsustainable; and more.